LEXINGTON, Mass.--(BUSINESS WIRE)-- Cubist Pharmaceuticals, Inc. (NAS: CBST) today reinforced its global commitment to the critical work of developing antibiotics for serious infections caused by ...

WASHINGTON, DC — The Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) is always an international affair, with about half of attendees coming from outside of the United States.

Chicago, Sept. 16, 2003 – Pharmacokinetic (PK) data from two clinical studies of the investigational HIV protease inhibitor (PI) 433908 (908) were presented here today at the 43rd Interscience ...

The role of ICAAC as a premier HIV meeting has clearly waned over the past few years. Nonetheless, on September 14, there were still a number of interesting oral presentations that provided us with ...

With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...

Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX), a late-stage pharmaceutical company focused on the development and commercialization of Locilex® (pexiganan cream 0.8%), and research collaborators, JMI ...

Data demonstrate potent, broad spectrum activity against gram-positive and gram-negative bacteria, including resistant organisms that cause skin infections "These updated microbiology data provide ...

YONKERS, NY--(Marketwired - Sep 2, 2014) - ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious diseases ...

EMERYVILLE, Calif., Sept. 8, 2010 (GLOBE NEWSWIRE) -- NovaBay Pharmaceuticals, Inc. (NYSE Amex:NBY), a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the ...

SAN DIEGO, Sept. 9, 2010 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced plans to present final results from the company's Phase 2 trial evaluating the potential for its TransVax™ ...